Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
The Journal of Pharmacology and Experimental Therapeutics|May 1, 2010
Characterizing the role of Thr352 in the inhibition of the large conductance Ca2+-activated K+ channels by 1-[1-hexyl-6-(methyloxy)-1H-indazol-3-yl]-2-methyl-1-propanoneEarl Gordon, Simon F Semus, Irina M Lozinskaya, et al.Molecular Pharmacology|November 29, 2007
2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channelsEarl Gordon, Irina M Lozinskaya, Zuojun Lin, et al.Journal of Biomolecular Screening|March 7, 2012
Perspectives on the discovery of small-molecule modulators for epigenetic processesQuinn Lu, Amy M Quinn, Mehul P Patel, et al.Journal of Medicinal Chemistry|September 29, 2006
A critical assessment of docking programs and scoring functionsGregory L Warren, C Webster Andrews, Anna-Maria Capelli, et al.Journal of Medicinal Chemistry|October 10, 2008
Potent, selective and orally bioavailable dihydropyrimidine inhibitors of Rho kinase (ROCK1) as potential therapeutic agents for cardiovascular diseasesClark A Sehon, Gren Z Wang, Andrew Q Viet, et al.Journal of Medicinal Chemistry|January 5, 2007
Development of dihydropyridone indazole amides as selective Rho-kinase inhibitorsKrista B Goodman, Haifeng Cui, Sarah E Dowdell, et al.Journal of Medicinal Chemistry|January 5, 2007
Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activityRobert A Stavenger, Haifeng Cui, Sarah E Dowdell, et al.Pageof 1